Skip to main content
. Author manuscript; available in PMC: 2022 Nov 16.
Published in final edited form as: Circulation. 2021 Oct 12;144(20):1612–1628. doi: 10.1161/CIRCULATIONAHA.121.053960

Figure 7. IFN-γ exposure depletes endothelial basal intracellular cGMP and impairs proliferation and migratory capacity.

Figure 7.

A-B, Intracellular cGMP levels from HCAEC quantified using ELISA following 25 h of IFN-γ treatment at 50 ng/mL. Absolute intracellular cGMP measurements normalized to total protein/plate (pmol/mg protein) (A) and relative intracellular cGMP levels expressed as the percentages of those of untreated control groups (B). Mean ± SEM from 8 biological replicates from 4 independent experiments.

C-F, HCAEC proliferation and migration capacities were assessed by scratch assay after IFN-γ exposure for 30 h. Representative bright field images are shown at 0 h (C-D) and 15 h the scratch (E-F).

G, Percentages of wound closure or monolayer re-endothelialization following IFN-γ treatment were calculated by the following formula = [(open area at 0 h) - (open area at 15 h)]/(open area at 0 h) × 100. Mean ± SEM from 3 independent experiments.

Statistical significance was assessed using a two-tailed Student’s t-test (A,G) or one-sample t-test (B).

* p < 0.05